Notably, this increase in TGFβ secretion was counteracted by pharmacological inhibition of STAT3 using STAT3-IN-12, indicating that tumor-conditioned media induce TGFβ production in a STAT3-dependent manner. This evidence concerns the gene TGFB1 and neoplasm.